Trials / Sponsors / iTeos Therapeutics
iTeos Therapeutics
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Advanced Solid Tumors | Phase 1 | 2023-07-07 |
| Active Not Recruiting | Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lun Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer | Phase 2 | 2022-08-26 |
| Terminated | Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 | 2022-05-01 |
| Completed | New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer Solid Tumor, Adult | Phase 1 | 2021-07-01 |
| Completed | First-In-Human Study of EOS884448 in Participants with Advanced Cancers. Advanced Cancer | Phase 1 | 2020-02-18 |
| Completed | First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer Solid Tumor, Adult | Phase 1 | 2019-02-05 |